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To determine whether age should inform our approach
toward permanent vascular access placement in patients
with chronic kidney disease, we conducted a retrospective
cohort study among 11 290 non-dialysis patients with an
estimated glomerular filtration rate (eGFR) o25 ml/min/
1.73 m2 based on 2000–2001 outpatient creatinine
measurements in the Department of Veterans Affairs. For
each age group, we examined the percentage of patients
that had and had not received a permanent access by 1 year
after cohort entry, and the percentage in each of these
groups that died, started dialysis, or survived without dialysis.
We also modeled the number of unnecessary procedures that
would have occurred in theoretical scenarios based on
existing vascular access guidelines. The mean eGFR was
17.7 ml/min/1.73 m2 at cohort entry. Twenty-five percent
(n¼ 2870) of patients initiated dialysis within a year of cohort
entry. Among these, only 39% (n¼ 1104) had undergone
surgery to place a permanent access beforehand. As
compared with younger patients, older patients were less
likely to undergo permanent access surgery, but also less
likely to start dialysis. In all theoretical scenarios examined,
older patients would have been more likely than younger
patients to receive unnecessary procedures. If all patients had
been referred for permanent access surgery at cohort entry,
the ratio of unnecessary to necessary procedures after
2 years of follow-up would have been 5:1 for patients
aged 85–100 years but only 0.5:1 for those aged
18–44 years. Currently recommended approaches to
permanent access placement based on a single threshold
level of renal function for patients of all ages are not
appropriate.
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Among patients initiating chronic hemodialysis, use of a
catheter rather than a more permanent form of vascular
access such as a graft or fistula, is associated with excess
morbidity, mortality, and cost.1–4 In order to reduce catheter
use among incident dialysis patients, it is generally agreed
that patients with chronic kidney disease (CKD) who are
expected to begin chronic dialysis should be referred
beforehand for surgery to create a permanent access. Ideally,
this referral should occur in enough time to allow for fistula
maturation and repeat attempts at fistula creation (if
necessary) before initiation of dialysis.5
Although there is broad agreement on the importance of
timely surgical referral for creation of a permanent access, most
patients in this country nevertheless start dialysis with a
catheter.6–10 A significant barrier to increasing the prevalence of
permanent access among incident hemodialysis patients has
been a lack of evidence to suggest exactly when patients with
non-dialysis-dependent CKD should be referred for this
surgery. In an individual patient, the expected time before
initiation of dialysis is usually unknown and clinical practice
guidelines on this topic are largely opinion-based and quite
variable. For example, the 2000 Kidney Disease Outcomes
Quality Initiative (KDOQI) guidelines recommended that
‘patients should be referred for surgery to attempt construction
of a primary AV fistula when their creatinine clearance is
o25 ml/min, their serum creatinine level is 44 mg/dl
(4352mmol/l), or within 1 year of an anticipated need for
dialysis.’5 In contrast, the 2006 Canadian Society of Nephrology
guidelines recommend that patients be referred at a ‘creatinine
clearance of 15 to 20 ml per min or serum creatinine of 3.4 mg/dl
to 5.6 mg/dl (300 to 500 mmol/l), depending on the size and
weight of the patient.’11 The recent 2006 KDOQI guideline
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recommends that patients be referred for fistula creation ‘at
least six months before the anticipated need for dialysis’ and
recommends that ‘patients with CKD stage 5 should bey
strongly encouraged to allow the evaluation for and creation
of a fistula for long-term access when appropriate.12,13
The question of when (and in whom) to place a
permanent access in preparation for hemodialysis is
a surprisingly complex one. Whereas the presence of a
functioning graft or fistula is associated with improved
outcomes among patients who begin dialysis, surgery to
create a permanent access is clearly undesirable in patients
who will never start dialysis, either because their CKD will
never progress to end-stage renal disease (ESRD) or because
they will die before needing dialysis. Placing permanent
access in such patients subjects them to all of the risks of
unnecessary surgery with no possible benefit. On the other
hand, from a public health point of view, a certain number of
unnecessary surgeries in patients who do not begin dialysis
may be tolerated in order to maximize the proportion of
patients who begin dialysis with a permanent access.
As described above, many guidelines identify an ideal
window of time before initiation of dialysis when permanent
access should be placed (e.g. 46 months for 2006 KDOQI
guideline, 41 year for 2000 KDOQI guideline). However,
perhaps because clinicians can rarely predict who will need
dialysis within a given time frame, most guidelines also
identify a target level of renal function at which patients
should be referred. This approach assumes a similar
relationship between level of renal function and progression
to ESRD among patients of all ages. However, at all levels of
renal function, older patients are relatively more likely to die
and less likely to start dialysis compared with younger
patients.14–19 We therefore hypothesized that use of a single
threshold level of estimated glomerular filtration rate (eGFR)
to guide referral for permanent access would have different
implications in older and younger patients. In the elderly, we
predicted that the tension between the need to place a
permanent access in patients who will begin dialysis and the
need to avoid unnecessary surgery in patients who will not
begin dialysis would be heightened.
RESULTS
Patients
There were 2 352 584 patients who underwent at least one
serum creatinine measurement within the United States
Department of Veterans Affairs (VA) between 1 October 2000
and 30 September 2001. Among these, we excluded 11 061
patients who had already reached ESRD at the time of
creatinine measurement. Among the remaining patients, we
identified 19 342 whose initial eGFR measurement during the
study period was o25 ml/min/1.73 m2. Because our study
focused on permanent vascular access for hemodialysis
(arteriovenous graft or fistula), we excluded 45 patients for
whom initial ESRD treatment during follow-up was trans-
plant and 433 patients whose initial dialysis modality was
peritoneal dialysis rather than hemodialysis. Among the
remaining 18 864 patients, we identified 11 290 who had a
repeat eGFRo25 ml/min/1.73 m2 at least 3 months after
cohort entry, or who started dialysis within 3 months of
cohort entry in order to delineate a study population with
clear evidence of a sustained eGFRo25 ml/min/1.73 m2.
The mean age of the patient cohort was 70 years (95%
confidence interval 69.8, 70.2), 2% (n¼ 246) were female
subjects, patient race was black in 22% (n¼ 2466), white in
70% (n¼ 7914), other in 6% (n¼ 707), and unknown in 2%
(n¼ 203). Diabetes was diagnosed in 56%, coronary artery
disease in 58%, congestive heart failure in 44%, peripheral
arterial disease in 36%, cerebrovascular disease in 28%,
chronic obstructive lung disease in 34%, and dementia in 7%.
Patient average eGFR was 17.7 ml/min/1.73 m2 at cohort
entry and was higher for older than for younger cohort
members (Table 1). The median annual decrement in eGFR
was 2.3 ml/min/1.73 m2 (25th to 75th percentile range 5.2
to 0.1 ml/min/1.73 m2) and was in general lower for older
than for younger cohort members (Table 1). These calcula-
tions were based on follow-up creatinine measurements
obtained a median of 530 days (25th to 75th percentile range
272–813 days) after cohort entry and 128 days (25th to 75th
percentile range 83–254 days) before initiation of dialysis,
death, or 30 September 2003, whichever came first.
Overall, 15% (n¼ 1728) of cohort patients initiated
dialysis within 6 months, 25% (n¼ 2870) within 1 year,
and 40% (n¼ 4502) within 2 years of cohort entry. However,
these percentages varied considerably by age group: 32, 47,
and 67%, respectively, for 18–44 year olds vs 8, 11, and 17%,
respectively, for 85–100 year olds. The percentage of patients
who died was 3% at 6 months, 9% at 1 year, and 22% at
2 years and also varied considerably by age group: 0.4, 4, and
6%, respectively, among 18–44 year olds vs 3, 17, and 41%,
respectively, among 85–100 year olds.
Table 1 | Baseline and median rate of decline in eGFR by age group
Age group
(years)
% with outpatient
nephrology visit by the end
of follow-up (95% CI)
Mean eGFR at cohort entry
(95% CI), ml/min/1.73m2
Median annual change in
eGFR (25th to 75th percentile
range), ml/min/1.73m2
18–44 75.2 (69.9, 80.5) 15.3 (14.6, 16.0) 3.4 (8.4, 1.5)
45–54 75.9 (73.4, 78.3) 15.7 (15.4, 16.0) 3.6 (7.6, 0.9)
55–64 75.9 (73.9, 77.8) 16.0 (16.7, 17.2) 3.2 (6.4, 0.6)
65–74 76.8 (75.5, 78.2) 17.9 (17.7, 18.0) 2.2 (5.0, +0.2)
75–84 69.8 (68.4, 71.3) 18.6 (18.5, 18.8) 1.9 (4.3, +0.4)
85–100 55.7 (51.1, 60.2) 18.8 (18.4, 19.2) 1.3 (4.0, +1.1)
CI, confidence interval; eGFR, estimated glomerular filtration rate.
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By 1 year after cohort entry, only 16% (n¼ 1919) of
cohort patients had undergone pre-dialysis permanent access
placement surgery. Among these, 30% (n¼ 572) had already
received a permanent access by the time of cohort entry and
the remainder (n¼ 1347) underwent pre-dialysis access
surgery during the year after cohort entry. Seventy-three
percent (n¼ 8269) of patients had at least one outpatient
nephrology encounter (as defined in the Materials and
Methods section) within 1 year of cohort entry (Table 1).
Twenty-five percent (n¼ 2870) of patients started dialysis
within 1 year of cohort entry. Among these, only 39%
(n¼ 1104/2870) had received a permanent access beforehand.
The percentage of cohort patients who had received a
permanent access by the end of 1 year follow-up decreased
dramatically with advancing age (Figure 1a). However,
among patients who initiated dialysis within 1 year of cohort
entry, there were no significant differences by age group in
the percentage that had received a permanent access before
dialysis initiation (Figure 1b), although the percentages were
lowest at the extremes of age. In older age groups, the
majority of patients either died without starting dialysis or
survived without needing dialysis (Figure 2). Overall, low
rates of permanent access placement in older patients
appeared to be roughly commensurate with low rates of
dialysis initiation at older ages. Rates of dialysis initiation
decreased from the youngest to the oldest age group within
each quartile of propensity score and regardless of whether
patients had an outpatient nephrology encounter (results not
shown).
In theoretical scenarios where patients received permanent
access at cohort entry based on a selection of different eGFR
thresholds, the ratio of unnecessary to necessary procedures
was always higher in older than in younger patients (Figure
3a–c). This pattern was most pronounced at higher threshold
levels of eGFR. For example, if all patients with an eGFR
o25 ml/min/1.73 m2 (i.e. all cohort patients) had been
referred for access surgery at cohort entry, the ratio of
unnecessary to necessary procedures even after 2 years of
follow-up would have been almost 5:1 for patients aged
85–100 years but only 0.5:1 for those aged 18–44 years.
Because the percentage of patients initiating dialysis increased
with falling eGFR in all age groups, among older patients
these ratios were markedly lower at lower eGFR referral
thresholds. In contrast, among younger patients, the ratio of
unnecessary to necessary procedures varied less between
scenarios.
DISCUSSION
In a large national cohort of VA patients with an
eGFRo25 ml/min/1.73 m2, most patients who initiated
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Figure 1 | Permanent vascular access surgeries by age group.
(a) Percent of all cohort patients who received pre-dialysis permanent
access by the end of follow-up. Estimates are provided with a 95%
confidence interval. (b) Percent of patients who initiated dialysis
during follow-up that had undergone permanent access placement
before initiation of dialysis. Estimates are provided with a 95%
confidence interval.
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Figure 2 | One year outcomes by age group.
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dialysis over a 1-year period had not been referred before-
hand for placement of permanent access. These findings
corroborate earlier studies in other populations identifying
pre-dialysis access placement as a priority area for quality
improvement.8,9 At the same time, substantial age differences
in rates of dialysis initiation in our cohort suggest that
a uniform approach to permanent access placement in
patients of all ages based solely on level of estimated renal
function (implicit in many guidelines) may not be an
optimal solution.
Lower rates of dialysis initiation among elderly patients
with CKD observed in the present study have been described
in a variety of different populations.14–19 In this cohort, such
age differences do not appear to be explained by confounding
by other measured patient characteristics but may reflect the
slower rate of eGFR decline, and higher competing risk of
death among older patients in this cohort. In addition, the
abbreviated Modification of Diet in Renal Disease equation
was not developed nor has it been validated in an older
population with severe CKD and thus may not provide
accurate estimates of true GFR in this population. Goals of
care may also be different among older patients, perhaps
reflected in the lower rates of nephrology referral among
cohort patients 75 years and older. Unfortunately, our data
sources were insufficiently detailed to determine whether age
differences in rates of conservative therapy (i.e. no dialysis or
transplant) for renal failure could account for lower rates of
dialysis initiation in this cohort. Regardless of the underlying
explanation, the group of patients who initiate dialysis (and
thus stand to benefit from permanent access surgery)
effectively becomes a ‘shrinking target’ at older ages.
Our results demonstrate that use of a single eGFR (or
presumably creatinine clearance) threshold to guide perma-
nent access placement in patients of all ages has the potential
to result in a disproportionately large number of unnecessary
procedures in older patients. For example, among patients
aged 85–100 years, placement of permanent access at an
eGFRo25 ml/min/1.73 m2 (consistent with the 2000 KDOQI
guideline) would have turned out to be necessary in only one
in six patients, even after 2 years of follow-up. On the other
hand, among patients aged 18–44 years with an eGFR
o25 ml/min/1.73 m2, the procedure would have been
necessary in one in three patients after only 6 months and
one in 1.5 patients after 2 years of follow-up. Identifying
which older patients are likely to start dialysis becomes
particularly challenging over the relatively short periods of
time recommended in some guidelines. For example, 2006
KDOQI guidelines recommend that access be placed at least 6
months before initiation of dialysis. However, even among
85–100 year olds with an eGFRo15 ml/min/1.73 m2, only one
in four patients started dialysis within six months and only
one in three patients started dialysis within a year. These
findings are important because unnecessary surgeries are
both costly and carry a risk to the patient with no benefit
during the time frame expected. Current Medicare reimbur-
sement for physician fees alone exceeds $500 for fistula
placement. This figure does not include hospital costs related
to the procedure or costs associated with repeat procedures
when the initial procedure is unsuccessful.
Although most practice guidelines implicitly favor a
uniform approach to permanent access placement for
patients of all ages, age did appear to influence placement
practices in this ‘real world’ clinical setting. Low rates of
permanent access placement in elderly compared with
younger cohort members were commensurate with low rates
of dialysis initiation at older ages. Overall, targeting of access
procedures to patients who initiated dialysis within 1 year of
cohort entry appeared to be no worse in older than in
younger cohort members. Rates of pre-dialysis access
placement among cohort members who initiated dialysis
were uniformly low for patients of all ages.
Low rates of pre-dialysis access placement among incident
dialysis patients of all ages signal the need for more effective
strategies to decrease catheter use among patients beginning
dialysis. Our results suggest that a ‘one size fits all’ approach
toward timing of permanent access placement may not be
appropriate. In younger patients, broad efforts to increase
permanent access placement at relatively high levels of
eGFR (e.g. o25 ml/min/1.73 m2 as recommended in the
2000 KDOQI guideline) are probably appropriate. In this
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Figure 3 | Ratio of unnecessary to necessary permanent access
surgeries at different theoretical referral eGFR thresholds by age
and length of follow-up. (a) Referral threshold eGFRo25 ml/min/
1.73 m2. (b) Referral threshold eGFRo20 ml/min/1.73 m2. (c) Referral
threshold eGFRo15 ml/min/1.73 m2.
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cohort, younger patients experienced a faster decline in
eGFR, a lower competing risk of mortality, and (perhaps for
these reasons) higher rates of dialysis initiation compared
with older patients. Therefore, the ratio of unnecessary to
necessary procedures would have been low in younger cohort
members, even if all had been referred for access at an
eGFRo25 ml/min/1.73 m2. On the other hand, in the elderly,
efforts to improve targeting of permanent access placement
to the subset of patients who are most likely to need dialysis
in the expected time frame may be more appropriate. Such
an approach might perhaps involve using a lower eGFR
threshold for referral for access surgery in the elderly as
modeled in this analysis (e.g. o15 ml/min/1.73 m2 as
recommended in the 2006 KDOQI guideline). For example,
referral of those aged 85–100 years at an eGFRo15 ml/min/
1.73 m2 would have incurred only 1.5 unnecessary surgeries
for every one patient that was necessary after 2 years of
follow-up. However, even at such low levels of eGFR, the
ratio of unnecessary to necessary procedures that would have
occurred among the oldest age group is still higher than for
the youngest age group if referred at an eGFRo25 ml/min/
1.73 m2. Thus, we would argue that age should influence our
approach to permanent access placement in patients with
CKD. A uniform approach to permanent access placement
may be appropriate in younger patients whose rates of
dialysis initiation are relatively high even at relatively
preserved levels of eGFR. However, in older patients,
additional predictors of progression to dialysis beyond eGFR
(e.g. proteinuria, change in eGFR, functional status) are
needed to identify those patients most likely to benefit from
permanent access placement.
Limitations include: (1) this analysis only examines the
timing of access placement surgeries. From the available data,
we cannot determine whether an access was functional at the
time of dialysis initiation. (2) We opted to define our cohort
based on two creatinine measurements drawn at least 3
months apart within the VA. This approach allowed us to
define a cohort of patients with evidence of a sustained
eGFRo25 ml/min/1.73 m2 whose care was most likely to be
captured in the VA and Medicare data sources available to us.
However, this approach involved excluding patients who died
within 3 months of cohort entry or did not have a repeat
creatinine measurement for other reasons and patients whose
repeat eGFR was 25 ml/min/1.73 m2 or greater. Thus, our
results may not be completely generalizable to all VA patients
who started dialysis during follow-up or to patients receiving
care outside our system. However, we would argue that
although selection bias may have influenced the absolute
frequency of different outcomes among cohort members,
such bias is unlikely to have greatly impacted the relationship
between age and outcome frequency. (3) Our study was
restricted to veteran health-care users and thus may not be
generalizable outside the VA system and in particular to
populations not well represented in our cohort (e.g. women
and patients belonging to Hispanic or other racial-ethnic
groups). However, although specific rates of permanent
access placement and death may differ for this cohort
compared with others, age-related differences in outcomes
are likely to be generalizable beyond the VA.
Conclusion
Rates of pre-dialysis permanent access surgery among
patients of all ages beginning dialysis are low and in need
of improvement. However, dramatic differences between age
groups in rates of chronic dialysis initiation suggest that a
uniform approach to surgical referral based on a single
threshold level of renal function among patients of all ages is
not the optimal solution. Although such an approach may be
appropriate in younger patients, our results call for a more
targeted approach in the elderly directed at the minority that
will begin dialysis within the desired time frame.
MATERIALS AND METHODS
Data sources
We used the VA Decision Support System (DSS) Laboratory Results
file to ascertain serum creatinine measurements associated with
outpatient visits among cohort patients. We used the VA National
Patient Care Database and Medicare denominator file and in-patient
and outpatient claims to ascertain demographic and comorbidity
information and to identify permanent access placement procedures
occurring before or within 1 year after cohort entry. We used the VA
Beneficiary Identification and Records Locator Sub-system (BIRLS)
to ascertain date of death. These data were then linked to the United
States Renal Data System (USRDS), a national ESRD registry, to
exclude prevalent ESRD patients from the cohort and to identify
new cases of treated ESRD occurring after cohort entry.
Covariates
Patient age was categorized as: 18–44, 45–54, 55–64, 65–74, 75–84,
and 85–100 years. GFR at cohort entry was estimated using the
abbreviated Modification of Diet in Renal Disease equation based on
serum creatinine, age, race, and sex.20
Study outcomes
To evaluate the impact of age on permanent access placement,
patients were classified into six categories based on 1 year outcomes:
whether they underwent pre-dialysis permanent access placement
and whether they initiated dialysis or died before onset of dialysis
within a year of cohort entry. We used both arteriovenous fistula and
graft Current Procedural Terminology (CPT) and International
Classification of Disease (ICD-9) procedure codes to identify
permanent access procedures (ICD-9 procedure codes 39.27 and
39.93 and CPT codes 36800, 36810, 36821, 36825, and 36830) using
both VA administrative and Medicare data. One year was selected
for this analysis, because this was the maximum follow-up time
available for vascular access procedures in the Medicare data
available to us.
In a separate analysis, we modeled theoretical scenarios defining
the percentage of patients who would have received unnecessary
vascular access procedures if vascular access had been placed at
cohort entry based on different threshold levels of eGFR.
Unnecessary procedures were defined as those performed in patients
who did not start dialysis (and thus would not have used their
access) within a given time frame. For these analyses, we varied the
time frame over which procedures were classified as necessary or
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unnecessary from 6 months up to 2 years. We were able to use a
longer follow-up time for this analysis than for the analysis
described above, because we were not examining actual access
placement procedures (for which we had more limited follow-up).
The study was approved by the Institutional Review Board at the
University of California, San Francisco and the Research and
Development Committee at the VA San Francisco.
Analysis
All analyses were conducted using Stata version 8.1. (Stata
Corporation, College Station Texas). We examined age differences
in mean eGFR at cohort entry and in median rate of eGFR decline
based on repeat creatinine measurements after cohort entry. For
each patient we identified the most recent serum creatinine level at
least 90 days after cohort entry and at least 60 days before onset of
ESRD, death or 30 September 2003 (whichever came first). To
calculate rate of eGFR decline, we then subtracted the eGFR at
cohort entry from the most recent eGFR during this interval, and
divided by the exact time between the two measurements. Because
the distribution of rate of eGFR decline was skewed, we report
median rather than mean annual decline in eGFR for each age
group. Patients who did not have a follow-up creatinine measure-
ment during the aforementioned time window (n¼ 2273) were
excluded from this analysis.
To evaluate the impact of age on vascular access placement
practices, we examined permanent access placement at different ages
both among all cohort patients and among the subgroup that
initiated dialysis within a year of cohort entry. For each point
estimate, we calculated exact 95% confidence intervals based on the
t-distribution.
To understand the extent to which permanent access placement
was targeted toward patients who started dialysis and away from
patients who died without initiating dialysis during follow-up, we
classified patients according to whether they initiated dialysis, died,
or survived for 1 year without needing dialysis. Patients with each
outcome were further classified according to whether or not they
had been referred for pre-dialysis permanent access placement either
before cohort entry or during 1 year follow-up. These analyses were
stratified by age group.
To determine whether our primary findings could be attributed
to differences across age groups in patient characteristics other than
age that were associated with mortality in this cohort, we developed
a propensity score to capture each patient’s propensity to die within
1 year of cohort entry based on race, sex, eGFR at cohort entry and
co-morbid conditions defined by ICD-9 and CPT codes before
cohort entry in in-patient and outpatient encounters under the VA
or Medicare. Specifically, we generated the propensity score using
logistic regression analysis where the dependent variable was death
within 1 year of cohort entry and the independent variables were
race (black, white, other, missing), sex, and diagnosed diabetes,
coronary artery disease, congestive heart failure, peripheral arterial
disease, chronic obstructive lung disease, cerebrovascular disease,
and dementia. Patients were then divided by quartile of propensity
score and the primary analysis was repeated among patients with
propensity scores in the lowest and highest quartiles, respectively.
To determine whether lower rates of access placement in older
patients were due to lower rates of referral to nephrology in the
elderly, we repeated the primary analysis among patients who had
and had not seen a nephrologist by 1 year after cohort entry. We
defined nephrology referral as a visit to nephrology clinic within the
VA or an outpatient encounter with a nephrology provider under
Medicare. We specified that the initial nephrology appointment
must have occurred before the initial pre-dialysis access placement
procedure among those who underwent this procedure and before
initiation of dialysis among those who initiated dialysis without
having undergone prior permanent access placement.
In a separate analysis, we estimated the number of unnecessary
procedures that would have occurred in each age group if all patients
had received permanent access at cohort entry based on rates of
death and dialysis initiation among cohort members. For this
analysis, we varied both the level of eGFR at which access would
theoretically be placed to correspond approximately with what is
recommended in different guidelines (o25,o20, ando15 ml/min/
1.73 m2). We also varied the follow-up time over which a procedure
was judged necessary vs unnecessary (6 months, 1 and 2 years after
cohort entry).
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